January 2010 - Global Information would like to present a new market research report, "Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies" by Business Insights.
One of the major issues confronting both the pharmaceutical and biopharmaceutical industries is the requirement to a) reduce the escalating costs and risks associated with drug development and b) reduce clinical trial timelines by improving patient recruitment and improving the efficiency of clinical trial results analysis and reporting.
The pharmaceutical and biopharmaceutical industry have recognised the opportunities and advantages that exist by conducting clinical trials in what is referred to as the emerging markets. This report analyses the background to these markets including a review of the relevant legislation and regulations governing the control of clinical trials in the key emerging markets as well as analysing the implications and factors which need to be taken into consideration when conducting clinical trials in these markets.
Business Insights